Sernova CEO Philip Toleikis

“This is Becoming a Reality” – Sernova’s Cell Therapy Approach to a Functional T1D Cure

Big news from Sernova, one of the companies hoping that implantable stem cells will be a functional cure for diabetes. They recently announced that the first person in their trials with type 1 is completely off injected or infused insulin – and is making their own. Stacey talks to Dr. Philip Toleikis, Sernova’s president and…

Stacey and Kevin Sayer on Zoom. Kevin holds up a box with G7 on the side

“Dexcom is Preparing for the Future” CEO Kevin Sayer on G7, the international market, competitors and more

Dexcom CEO Kevin Sayer joins Stacey from the American Diabetes Association’s Scientific Sessions with new G7 information, a response to Abbott’s Libre 3 approval, addressing rumors about acquiring another diabetes company and a lot more. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care…